ProPhase Labs, Inc. Interest and Other Income
ProPhase Labs, Inc. (PRPH) reported Interest and Other Income of $327.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-28.
Discontinued › Income Statement › Other Income
us-gaap:InterestAndOtherIncome · last filed 2018-03-28
- ProPhase Labs, Inc. interest and other income for the quarter ending 2014-12-31 was $1.00K.
- ProPhase Labs, Inc. interest and other income for the quarter ending 2014-09-30 was $1.00K.
- ProPhase Labs, Inc. interest and other income for the quarter ending 2014-06-30 was $1.00K, a 0.00% change year-over-year.
- ProPhase Labs, Inc. interest and other income for the quarter ending 2014-03-31 was $0.00.
- ProPhase Labs, Inc. interest and other income for fiscal 2017 was $327.00K.
- ProPhase Labs, Inc. interest and other income for fiscal 2016 was -$212.00K.
- ProPhase Labs, Inc. interest and other income for fiscal 2015 was -$16.00K, a 500.00% decline from fiscal 2014.
- ProPhase Labs, Inc. interest and other income for fiscal 2014 was $4.00K, a 100.00% increase from fiscal 2013.
| Period end | Interest and Other Income 3 month | Interest and Other Income 6 month | Interest and Other Income 9 month | Interest and Other Income 12 month |
|---|---|---|---|---|
| 2017-12-31 | $327.00K 10-K · filed 2018-03-28 | |||
| 2016-12-31 | -$212.00K 10-K · filed 2018-03-28 | |||
| 2015-12-31 | -$16.00K 10-K · filed 2018-03-28 | |||
| 2014-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $2.00K derived: sum of 2 quarters · filed 2015-03-27 | $3.00K derived: sum of 3 quarters · filed 2015-03-27 | $4.00K 10-K · filed 2015-03-27 |
| 2014-09-30 | $1.00K 10-Q · filed 2014-11-13 | $2.00K derived: sum of 2 quarters · filed 2014-11-13 | $3.00K 10-Q · filed 2014-11-13 | $2.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2014-06-30 | $1.00K 10-Q · filed 2014-08-12 | $1.00K 10-Q · filed 2014-08-12 | $1.00K derived: sum of 3 quarters · filed 2015-03-27 | $1.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2015-03-27 | $0.00 derived: sum of 3 quarters · filed 2015-03-27 | $1.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $0.00 derived: sum of 2 quarters · filed 2015-03-27 | $1.00K derived: sum of 3 quarters · filed 2015-03-27 | $2.00K 10-K · filed 2015-03-27 |
| 2013-09-30 | $0.00 10-Q · filed 2014-11-13 | $1.00K derived: sum of 2 quarters · filed 2014-11-13 | $2.00K 10-Q · filed 2014-11-13 | $2.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2013-06-30 | $1.00K 10-Q · filed 2014-08-12 | $1.00K 10-Q · filed 2014-08-12 | $2.00K derived: sum of 3 quarters · filed 2015-03-27 | $3.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 | $1.00K derived: sum of 2 quarters · filed 2015-03-27 | $2.00K derived: sum of 3 quarters · filed 2015-03-27 | $4.00K derived: sum of 4 quarters · filed 2015-03-27 |
| 2012-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $2.00K derived: sum of 2 quarters · filed 2015-03-27 | $4.00K derived: sum of 3 quarters · filed 2015-03-27 | $7.00K 10-K · filed 2015-03-27 |
| 2012-09-30 | $1.00K 10-Q · filed 2013-11-13 | $3.00K derived: sum of 2 quarters · filed 2013-11-13 | $6.00K 10-Q · filed 2013-11-13 | $7.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2012-06-30 | $2.00K 10-Q · filed 2013-08-13 | $5.00K 10-Q · filed 2013-08-13 | $6.00K derived: sum of 3 quarters · filed 2014-03-27 | $10.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2012-03-31 | $2.00K 10-Q · filed 2013-05-10 | $4.00K derived: sum of 2 quarters · filed 2014-03-27 | $8.00K derived: sum of 3 quarters · filed 2014-03-27 | $17.00K derived: sum of 4 quarters · filed 2014-03-27 |
| 2011-12-31 | $2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $6.00K derived: sum of 2 quarters · filed 2014-03-27 | $15.00K derived: sum of 3 quarters · filed 2014-03-27 | $28.00K 10-K · filed 2014-03-27 |
| 2011-09-30 | $4.00K 10-Q · filed 2012-11-14 | $13.00K derived: sum of 2 quarters · filed 2012-11-14 | $26.00K 10-Q · filed 2012-11-14 | $37.00K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-06-30 | $9.00K 10-Q · filed 2012-08-13 | $21.00K 10-Q · filed 2012-08-13 | $33.00K derived: sum of 3 quarters · filed 2013-03-28 | $45.00K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-03-31 | $12.00K 10-Q · filed 2012-05-11 | $24.00K derived: sum of 2 quarters · filed 2013-03-28 | $36.00K derived: sum of 3 quarters · filed 2013-03-28 | $60.00K derived: sum of 4 quarters · filed 2013-03-28 |
| 2010-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $24.00K derived: sum of 2 quarters · filed 2013-03-28 | $48.00K derived: sum of 3 quarters · filed 2013-03-28 | $53.00K 10-K · filed 2013-03-28 |
| 2010-09-30 | $12.00K 10-Q · filed 2011-11-14 | $36.00K derived: sum of 2 quarters · filed 2011-11-14 | $41.00K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $24.00K 10-Q · filed 2011-08-12 | $26.00K 10-Q · filed 2011-08-12 | ||
| 2009-12-31 | $9.00K 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |